Role of extraceullar vesicles in directing immunometabolic homeostasis after burn injury

细胞外囊泡在烧伤后指导免疫代谢稳态中的作用

基本信息

  • 批准号:
    10337838
  • 负责人:
  • 金额:
    $ 1.74万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-12-15 至 2022-11-30
  • 项目状态:
    已结题

项目摘要

ABSTRACT The research and training plan put forth in this Diversity Supplement will build upon key findings generated under the parent application by the pre-doctoral candidate (Micah LaTrell Willis). This Research Plan and the Training Plan submitted will provide Mr. Willis with opportunities to not only build an intellectual and technical toolbox to propel him towards the next phase of his trainee/development but provide him the career development opportunities to ensure he obtains his short and long-term career goals. Thus, support from this this Diversity Supplement will empower Mr. Willis to own and drive his research, training, and career development plans. Severe burn injury is one of the most devastating forms of trauma, with mortality rates reaching up to 12% even in specialized burn centers. Combined inhalation injury further increases this mortality rate. The primary cause of mortality are opportunistic infections which occur days to weeks after the injury, often resulting in lethal pneumonias and/or sepsis from bacteremia. Burn-induced immune dysfunction underlies this prolonged susceptibility to infection. It is known that response to bacterial infections is induced and regulated by Toll-like Receptor (TLR) and associated MyD88 signaling, causing release of key inflammatory cytokines. With our parent NIGMS grant “Damage-Induced Activation of the TLR/mTOR/PPARg Axis Regulates the Immune Response After Burn and Inhalation Injury” (R01GM131124), we are currently investigating in human and pre-clinical studies that immune dysfunction after burn and inhalation injury involves aberrant MyD88-mediated TLR signaling by damage associated molecular pattern molecules (DAMPs) released after injury. This results in aberrant cytokine signaling, with macrophages, neutrophils and endothelial cells (EC) playing key roles. Extracellular vesicles have emerged as novel mediators of immune dysfunction across several immune pathologies. Microvesicles (MVs) are a class of extracellular vesicles that carry DAMPs, cytokines, and miRNAs, to regulate functions of recipient cells. We have found that MVs are a key reservoir for DAMPs, cytokines, and potent immune complexes after burn injury in humans and mice. Given our findings, and the key role of MVs in multiple immune conditions, we hypothesize that MVs drive the immune dysfunction associated with poor clinical outcomes in severe burn injury. These findings are highly synergistic with the Specific Aims of the parent grant. Using same patient and mouse tissue (utilizing our established pre-clinical model of burn and inhalation injury, and repository of human burn patient samples) derived during the parent grant’s experimental plan, we aim to further characterize the payload (Supplement Aim 1) and immune function (Supplement Aim 2) of MVs isolated from plasma after injury. This will allow us to incorporate MVs into the Immune Suppression Index (ISI) developed in the parent grant to identify burn patients at low and high risk for subsequent bacterial infection to improve prognostic value
抽象的 这种多样性补充剂中提出的研究和培训计划将基于根据 博士前候选人(Micah Latrell Willis)的父申请。该研究计划和培训 提交的计划将为威利斯先生提供机会,不仅建立一个智力和技术工具箱 推动他进入实习生/发展的下一阶段,但为他提供职业发展 确保他实现短期和长期职业目标的机会。这是从这种多样性中的支持 补充剂将使威利斯先生能够拥有并推动其研究,培训和职业发展计划。 严重的烧伤是最具破坏性的创伤形式之一,死亡率甚至达到12% 在专门的烧伤中心。联合吸入损伤进一步提高了这一死亡率。主要原因 死亡率是机会感染,受伤后几天发生,通常导致致命 细菌血症的肺炎和/或败血症。燃烧引起的免疫功能障碍是延长的 感染的敏感性。众所周知,对细菌感染的反应是由Toll样诱导和调节的 受体(TLR)和相关的MYD88信号传导,导致关键炎症细胞因子的释放。和我们的父母在一起 NIGMS Grant“损伤引起的TLR/MTOR/PPARG轴的激活调节免疫反应 燃烧和吸入损伤之后”(R01GM131124),我们目前正在人类和临床前进行研究 燃烧和吸入损伤后免疫功能障碍的研究涉及异常MyD88介导的TLR 受伤后通过损伤相关的分子模式分子(湿)信号传导。这导致 异常的细胞因子信号传导,具有巨噬细胞,中性粒细胞和内皮细胞(EC)发挥关键作用。 细胞外蔬菜已成为几种免疫功能障碍的新型免疫功能障碍介质 病理。微泡(MV)是一类细胞外蔬菜,携带湿,细胞因子和miRNA, 调节受体细胞的功能。我们发现MV是潮湿,细胞因子和 人类和小鼠烧伤后有效的免疫复合物。鉴于我们的发现以及MV在 多种免疫条件,我们假设MVS驱动与临床不良相关的免疫功能障碍 严重烧伤的结果。这些发现与父母的具体目的高度协同 授予。使用同一患者和小鼠组织(利用我们已建立的临床前燃烧和吸入模型 在父母赠款的实验计划期间得出的伤害和人类烧伤患者样本的存储库,我们 旨在进一步表征有效载荷(补充AIM 1)和免疫功能(补充AIM 2)MVS 受伤后从血浆中分离出来。这将使我们能够将MV纳入免疫抑制指数(ISI) 在父母赠款中开发的,以识别以后细菌感染的低风险和高风险的烧伤患者 提高预后价值

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bruce A Cairns其他文献

Bruce A Cairns的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bruce A Cairns', 18)}}的其他基金

Multi-modal rescue of pulmonary NRF2-insufficiency after burn and burn + inhalation injury to regulate innate immune dysfunction
烧伤及烧伤吸入性损伤后肺NRF2不足的多模式抢救调节先天免疫功能障碍
  • 批准号:
    10435748
  • 财政年份:
    2022
  • 资助金额:
    $ 1.74万
  • 项目类别:
Multi-modal rescue of pulmonary NRF2-insufficiency after burn and burn + inhalation injury to regulate innate immune dysfunction
烧伤及烧伤吸入性损伤后肺NRF2不足的多模式抢救调节先天免疫功能障碍
  • 批准号:
    10732822
  • 财政年份:
    2022
  • 资助金额:
    $ 1.74万
  • 项目类别:
Multi-modal rescue of pulmonary NRF2-insufficiency after burn and burn + inhalation injury to regulate innate immune dysfunction
烧伤及烧伤吸入性损伤后肺NRF2不足的多模式抢救调节先天免疫功能障碍
  • 批准号:
    10651857
  • 财政年份:
    2022
  • 资助金额:
    $ 1.74万
  • 项目类别:
Damage-Induced Activation of the TLR/mTOR/PPARg Axis Regulates the Immune Response After Burn and Inhalation Injury
损伤诱导的 TLR/mTOR/PPARg 轴激活调节烧伤和吸入性损伤后的免疫反应
  • 批准号:
    10300052
  • 财政年份:
    2018
  • 资助金额:
    $ 1.74万
  • 项目类别:
Damage-Induced Activation of the TLR/mTOR/PPARg Axis Regulates the Immune Response After Burn and Inhalation Injury
损伤诱导的 TLR/mTOR/PPARg 轴激活调节烧伤和吸入性损伤后的免疫反应
  • 批准号:
    10062997
  • 财政年份:
    2018
  • 资助金额:
    $ 1.74万
  • 项目类别:
Damage-Induced Activation of the TLR/mTOR/PPARg Axis Regulates the Immune Response After Burn and Inhalation Injury
损伤诱导的 TLR/mTOR/PPARg 轴激活调节烧伤和吸入性损伤后的免疫反应
  • 批准号:
    10531808
  • 财政年份:
    2018
  • 资助金额:
    $ 1.74万
  • 项目类别:
Microfluidic Nitric Oxide Sensor
微流控一氧化氮传感器
  • 批准号:
    9347968
  • 财政年份:
    2014
  • 资助金额:
    $ 1.74万
  • 项目类别:
Cellular mechanism of immune dysfunction following burn injury
烧伤后免疫功能障碍的细胞机制
  • 批准号:
    8445370
  • 财政年份:
    2009
  • 资助金额:
    $ 1.74万
  • 项目类别:
Cellular mechanism of immune dysfunction following burn injury
烧伤后免疫功能障碍的细胞机制
  • 批准号:
    7799750
  • 财政年份:
    2009
  • 资助金额:
    $ 1.74万
  • 项目类别:
Cellular mechanism of immune dysfunction following burn injury
烧伤后免疫功能障碍的细胞机制
  • 批准号:
    8244359
  • 财政年份:
    2009
  • 资助金额:
    $ 1.74万
  • 项目类别:

相似国自然基金

髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
  • 批准号:
    82372496
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
  • 批准号:
    82300396
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
  • 批准号:
    32370568
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
  • 批准号:
    82360332
  • 批准年份:
    2023
  • 资助金额:
    31.00 万元
  • 项目类别:
    地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
  • 批准号:
    82303057
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
  • 批准号:
    10696749
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Neural Inflammation and Exercise Pressor Reflex in Heart Failure
心力衰竭中的神经炎症和运动升压反射
  • 批准号:
    10712202
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Clinical Phase I trials on an IND single molecule dual inhibitor of Cav3 channels and soluble epoxide hydrolase for treatment of neuropathic pain
Cav3通道和可溶性环氧化物水解酶的单分子双重抑制剂治疗神经性疼痛的IND临床I期试验
  • 批准号:
    10760089
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
Resolvin receptor signaling in trigeminal sensory neurons
三叉神经感觉神经元中的 Resolvin 受体信号传导
  • 批准号:
    10738862
  • 财政年份:
    2023
  • 资助金额:
    $ 1.74万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了